1. Aebersold P, Hyatt C, Johnson S, et al. Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: Association with clinical response. J Natl Cancer Inst 1991;83:932–937.
2. Aoki Y, Takakuwa K, Kodama S, et al. Use of adoptive transfer of tumor-infiltrating lymphocytes alone or in combination with cisplatin containing chemotherapy in patients with epithelial ovarian cancer. Cancer Research 1991; 51: 1934–1939.
3. Arienti F, Belli F, Rivoltini L, et al. Adoptive immunotherapy of advanced melanoma patients with interleukin- 2 (IL-2) and tumor infiltrating lymphocytes selected in vitro with low doses of IL-2. Cancer Immunol Immunother 1993; 36: 315–322.
4. Baxevanis CN, Dedoussis GVZ, Papadopoulos NG, et al. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer. Cancer 1994; 74: 1275–1282.
5. Belldegrun A, Muul LM, Rosenberg SA. Interleukin 2 expanded tumor infiltrating lymphocytes in human renal cell cancer: Isolation, characterization, and anti-tumor activity. Cancer Research 1988; 48: 206–214.